
Sign up to save your podcasts
Or
Did you know that estrogen receptor-targeting therapies could help reduce chemotherapy exposure and its associated toxicities in advanced HER2-positive disease? Credit available for this activity expires: 1/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002178?ecd=bdc_podcast_libsyn_mscpedu
4
77 ratings
Did you know that estrogen receptor-targeting therapies could help reduce chemotherapy exposure and its associated toxicities in advanced HER2-positive disease? Credit available for this activity expires: 1/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002178?ecd=bdc_podcast_libsyn_mscpedu
135 Listeners
13 Listeners
315 Listeners
107 Listeners
865 Listeners
251 Listeners
495 Listeners
686 Listeners
18 Listeners
279 Listeners
3,321 Listeners
1,108 Listeners
195 Listeners
517 Listeners
349 Listeners
60 Listeners
25 Listeners
426 Listeners
366 Listeners